---
title: "David E. Lazar Becomes CEO and Chair at Aterian with 95.7% Stake"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/298649400.md"
description: "David E. Lazar has become CEO and Chair of Aterian, Inc., holding a 95.7% stake acquired via $7M in preferred stock purchases and conversions. Following shareholder approval, Lazar plans to pursue strategic opportunities, including potential acquisitions or mergers, and holds rights to nominate directors. This move reflects his background in small-cap turnarounds and controlling stake acquisitions."
datetime: "2026-09-10T21:56:01.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/298649400.md)
  - [en](https://longbridge.com/en/news/298649400.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/298649400.md)
generator: "portal-rs"
---

# David E. Lazar Becomes CEO and Chair at Aterian with 95.7% Stake

David E. Lazar disclosed a 95.7% ownership stake in Aterian, Inc.'s common stock in a Schedule 13D filed on Sep. 10, 2026. He gained the stake through a $7 million purchase of Series AA and Series AAA preferred stock and partial conversion completed after shareholder approvals on July 17, 2026. Lazar now serves as Aterian’s Chief Executive Officer and Chair, giving him significant influence over strategy and governance.

**Investor Intent**

Lazar plans to "evaluate and pursue strategic opportunities for Aterian, which may include an investment in, or acquisition of, an operating business." He also holds rights to nominate directors, and two of his designees already joined the board alongside his appointment as CEO and Chair.

He may buy more shares, convert additional preferred stock, or sell holdings as he reviews the company’s progress. He states he could recommend further board changes and capital moves, and may consider mergers, asset sales, or other major transactions.

**Investor's Background**

David E. Lazar is a Portugal-born investor and corporate executive who focuses on small-cap turnarounds. He often acquires controlling stakes, installs new boards, and pursues restructurings to revive struggling companies. He currently leads Aterian, Inc. as Chief Executive Officer and Chair.

Original SEC Filing: Aterian, Inc. \[ ATER \] - SCHEDULE 13D - Sep. 10, 2026

**Disclaimer**

This is an AI-powered summary. It may contain inaccuracies. Consider verifying important information with the source. Please note this summary is solely based on documents filed with the SEC.

### Related Stocks

- [ATER.US](https://longbridge.com/en/quote/ATER.US.md)

## Related News & Research

- [Aterian adjourns special shareholder meeting to July 17 from July 10](https://longbridge.com/en/news/292494283.md)
- [EQT Board Seeks Higher Bids as TPG and BGH Reaffirm Takeover Interest](https://longbridge.com/en/news/299570413.md)
- [HBM Healthcare Investments says Electra Therapeutics IPO raises USD 350 million](https://longbridge.com/en/news/299591426.md)
- [UBS CEO Ermotti warns against harsh capital rules ahead of vote](https://longbridge.com/en/news/299565274.md)
- [3 U.S. Life Insurance Stocks Built For Higher Interest Rates](https://longbridge.com/en/news/299566968.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**